全球慢性肾脏病患病率评估的局限性  

The limitations of the prevalence assessment of global chronic kidney disease

作　　者：孙柯 梅长林 

机构地区：[1]海军军医大学附属长征医院肾内科中国人民解放军肾脏病研究所,上海200003

出　　处：《中国临床医学》2017年第6期958-963,共6页Chinese Journal of Clinical Medicine

基　　金：国家重点研究发展计划(2016YFC0901502)~~

摘　　要：慢性肾脏病(chronic kidney disease,CKD)是全球范围内常见的疾病,目前主要根据肾脏结构或功能的异常来定义,通过肾小球滤过率(glomerular filtration rate,GFR)来评估。但CKD患病率的评估在不同国家间差异很大,影响因素很多。因此,本文就CKD患病率差异的影响因素作一综述,并进一步提出改进方法,以更准确地评估GFR,从而实现对部分CKD患者更精准的CKD分期。Chronic kidney disease（CKD）is currently defined by renal structural or functional abnormalities and is primarily assessed by glomerular filtration rate（GFR）.It＇s currently considered a common disease worldwide.However,the prevalence assessment of CKD varies greatly among different countries,and the influencing factors are many.Therefore,this article reviews the factors influencing the prevalence of CKD,and proposes improvement methods to assess GFR more accurately,so as to achieve more accurate CKD staging for some CKD patients.

关 键 词：慢性肾脏病 肾小球滤过率 研究进展 

分 类 号：R692[医药卫生—泌尿科学]